Our prowess in identifying some of the best quick strike options idea around is always showing itself. We signaled two more fresh options ideas in yesterday morning’s premarket report, and despite a down day for the markets, our ideas managed to buck the trend, and produce single-session gain opportunities of a significant nature.
BIDU and MDT were both post-earnings plays and they both yielded some nice potential profits, to the tune of multi-bag moves in every single set of targeted contracts:
Baidu, Inc. BIDU Weekly $113-116 Calls $113 Calls – Range: 1.18-2.51 – Max Gain: 113% $114 Calls – Range: .87-2.03 – Max Gain: 133% $115 Calls – Range: .67-1.65 – Max Gain: 146% $116 Calls – Range: .52-1.38 – Max Gain: 165%
In yesterday morning’s premarket report, one of the idea we included for some quick-stike options trading possibilities were the JD Weekly 27.50-29.50 Calls. They were our clear-cut winners of the day after the company beat on Q2 sales and earnings, aided by a reasonably bullish day for the markets at large.
Each and every contract in our highlighted range produced absolutely huge multi-bag intraday gain opportunities on the day for anyone with some skin in the game. Those moves were as follows:
$27.50 Calls – Range: 1.05-3.49 – Max Gain: 235% $28 Calls – Range: .76-3.00 – Max Gain: 295% $28.50 Calls – Range: .52-2.50 – Max Gain: 381% $29 Calls – Range: .32-2.05 – Max Gain: 541% $29.50 Calls – Range: .21-1.60 – Max Gain: 662%
Fresh Options Ideas:
HUYA Inc. HUYA Weekly $21-22 Calls
Agilent technologies, Inc. A 9/20 $65-70 Calls
Taronis Technologies, Inc. TRNX
We’re back to update on TRNX for the second straight session today. The stock turned in one heck of an intraday performance for us yesterday, trading in a range from .55 to a new high of .96. That’s an intraday rise of 75% and TRNX highest PPS since April.
From the .1832 low we observed following our initial alert last month, yesterday’s new high mark represents an overall increase of 424%
We took the opportunity to jump on some AYI calls following a poor showing from the company’s Q3 financials. We felt that the blow taken by the stock in the previous session was an overreaction, and decided to radar a couple of sets of contracts in the AYI chain to correspond with what we assumed would be a rebound from this burst of overselling,
Our targets were the AYI 07/19 $125-130 Calls. We banked on a course correction to provide us with a push and things turned out just as we hoped they might. The stock traded in a daily range from a low of 129.90 and cruised as high as 136.74. That allowed for some very respectable intraday gain opportunities for us, and we will want to continue to monitor these in the sessions ahead.
The $125 Calls ran from 6.10-11.55 for a daily rip of 89% while the $130′s went from 2.85-7.20, a gain of 153% A full two weeks remain before these contracts expire.
KB Homes KBH – Recap
We also signaled our interest in some KBH calls last Thursday. Since that time, the stock has been slowly creeping upward, and we’ve realized the potential for some very nice moves in our KBH 07/19 $26-27 Calls, which experienced their lows on the morning of our initial alert, and reached new highs yesterday.
The $26 Calls ran from .35-1.05, for an even 200% burst, while the $27′s fared slightly better. Those produced a move from .15-.47, signifying a run of 213%
LiteLink Technologies, Inc. (OTCMKTS:LLNKF)(CSE:LLT) – Update
When we profiled LLNKF in a special report yesterday morning, we mentioned that the stock was ‘dripping with upside potential‘, and we were essentially proven right immediately. The stock traded more volume than the two prior sessions combined (23X the 30-day average) as it ran from a low of .1157 on up to .197, which represented an intraday rise of 70%
LLNKF closed just a couple of ticks below its high of day, at .195, and anytime we see a stock do so, especially with increased volume and buying pressure, we definitely want to be on the lookout for a possible continuation of momentum. We’ll look for this play to register higher highs and higher lows and continue this bullish uptrend.
Zynerba Pharmaceuticals, Inc. ZYNE – Recap
We are going to revisit ZYNE this morning, a stock that we have been tracking since back in December, with a followup at the end of January, as well as another just a couple of weeks ago on April 30th. Throughout that period of time, ZYNE has appreciated by leaps and bounds.
Starting from the low we observed shortly following our December alert, at 2.75, the stock has run all the way up to an impressive new high of 15.98 this week. That marks an overall move of 481% since we’ve been watching this play. Readers who may have only caught the most recent report on April 30th, have still seen a range of 9.57-15.98- a very respectable upswing of 67%
As our regular readers are well aware, a majority of our focus in recent years has been shifted from straight stock trading ideas to options. More specifically, short-term options in companies that have just reported their quarterly earnings.
We are the absolute best newsletter for options daytrading in existence, routinely providing ideas with multi-bag gain potential each and every week. Our record, which anyone can view at any time in our archives, speaks for itself.
After a huge number of reporting companies just released their quarterlies and several high impact economic reports came back positive this morning, we’re going to revisit some ideas in a few chains that have been good to us in the past:
Biogen, Inc. BIIB has been largely trading sideways since its huge flop on its alzheimer’s drug back in March caused a massive cratering of the stock. We look for large gaps on charts like this, along with signs that a stock has reached its lowest likely trading value. The latter signal, we can infer from the huge blocks of insider buying at current levels which have been reported over the past week. Two Form-4′s amounting to a total of roughly $20M in insider buys suggest that the current base is solid. We’ll look to take advantage of a longer-term idea and track the BIIB 07/19 $240-250 Calls.
ARCA Biopharma, Inc. ABIO
Occasionally we do still provide straight stock ideas as well, when a solid bottom or news play catches our attention. We put ABIO on bottom watch at the end of March when it was trading in the upper-$6 to $7 range. The stock was under steady consolidation for the whole of April, and reached as low as 5.01 just this week before launching into a huge two day uptrend.
Yesterday it reached a new high of 20.45, which marks an overall rise of 308% We also re-tagged it in our premarket report yesterday, and for those that only put it on their radars following that alert, yesterday’s intraday move alone was fairly impressive. It ran from 12.03 up to the previously mentioned high, which marks a one day upswing of 70%